Itrungar capsules 100 mg. №4

Itrungar capsules 100 mg. №4

$12.00

Manufacturer: India

Fungal infections, caused by susceptible to Itraconazole agents: vulvovaginal candidiasis Dermatology / ophthalmological fungal diseases: dermatomycosis, lichen bran; fungal keratitis; oral candidiasis onychomycosis caused by dermatophytes, yeast; systemic mycosis systemic aspergillosis or candidiasis, cryptococcosis, including cryptococcal meningitis (imunoslablenim patients with cryptococcosis and all patients with cryptococcosis of the Central nervous system, the drug can be prescribed only if treatment with other antifungal drugs is ineffective); histoplasmosis, sporotrichosis, paracoccidioidosis, blastomycosis, and other systemic mycoses that are extremely rare.

Category:

Description

Itrungar Composition
Active substance: itraconazole;

1 capsule contains 100 mg of itraconazole;

Excipients: hydroxypropyl methylcellulose, corn starch, sucrose;

Capsule shell: body: yellow quinoline (E 104), titanium dioxide (E 171), methylparaben (E 218), propylparaben (E 219), sodium lauryl sulfate, purified water, gelatin; cap: FD & C green No. 3, titanium dioxide (E 171), methylparaben (E 218), propylparaben (E 219), sodium lauryl sulfate, purified water, gelatin.

Itrungar Contraindications
Itrungar capsules are contraindicated in patients with known hypersensitivity to the drug or its components.

The use of Itrungar capsules is contraindicated in patients with ventricular dysfunction, such as congestive heart failure, or a history of congestive heart failure, except for the treatment of life-threatening infections.

You should not use Itrungar capsules during pregnancy, except for the treatment of conditions that threaten the life of the mother.

Itrungar Mode of application
Apply internally. For optimal absorption of the drug, it is necessary to use Itrungar capsules immediately after taking a high-calorie meal.

The capsules should be swallowed whole.

Application features
Pregnant
Contraindicated.

Children
Since there is insufficient clinical data on the use of the drug in capsules for children, it is recommended to use itraconazole for such patients only when the benefit significantly outweighs the potential risk.

Drivers
Carefully.

Overdose
There are no data on cases of overdose. Possible increased side effects of the drug.

Treatment is symptomatic and supportive. There is no specific antidote for itraconazole. The active substance is not excreted during hemodialysis.

Side effects
The most common adverse reactions of itraconazole were gastrointestinal, dermatological and hepatic reactions.

From the gastrointestinal tract: pancreatitis, abdominal pain, nausea, vomiting, dyspepsia, diarrhea, constipation, dysgeusia, bloating.

From the digestive system: serious hepatotoxicity (including isolated cases of fatal acute liver failure), hepatitis, a reversible increase in the level of liver enzymes.

Storage conditions
Keep out of the reach of children in the original packaging at a temperature not exceeding 25 ° C.

Related products